ACADIA Pharmaceuticals shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of ACADIA Pharmaceuticals (ACAD) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in ACADIA Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including ACADIA Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in ACADIA Pharmaceuticals by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $21M | 661k | 31.31 |
| 2023-09-30 | $9.5M | 458k | 20.84 |
| 2023-06-30 | $6.7M | 281k | 23.95 |
| 2023-03-31 | $82M | 1.4M | 57.57 |
| 2022-12-31 | $33M | 2.1M | 15.92 |
| 2022-06-30 | $27M | 1.9M | 14.09 |
| 2022-03-31 | $57M | 2.3M | 24.49 |
| 2021-12-31 | $52M | 2.2M | 23.66 |
| 2021-03-31 | $36M | 1.4M | 25.92 |
| 2020-12-31 | $50M | 942k | 53.33 |
| 2020-09-30 | $35M | 870k | 39.96 |
| 2020-06-30 | $52M | 1.1M | 48.12 |
| 2020-03-31 | $47M | 1.1M | 42.35 |
| 2019-12-31 | $48M | 1.1M | 42.75 |
| 2019-09-30 | $40M | 1.1M | 36.00 |
| 2019-06-30 | $31M | 1.2M | 26.52 |
| 2019-03-31 | $22M | 807k | 26.85 |
| 2018-12-31 | $14M | 821k | 16.47 |
| 2018-09-30 | $17M | 811k | 20.78 |
| 2018-06-30 | $7.6M | 498k | 15.21 |
| 2018-03-31 | $42M | 1.9M | 21.88 |
| 2017-12-31 | $58M | 1.9M | 29.93 |
| 2017-06-30 | $51M | 1.9M | 27.24 |
| 2017-03-31 | $60M | 1.8M | 33.65 |
| 2016-12-31 | $61M | 2.1M | 29.63 |
| 2016-09-30 | $50M | 1.6M | 31.82 |
| 2016-06-30 | $29M | 897k | 32.71 |
| 2016-03-31 | $31M | 1.0M | 30.30 |
| 2015-12-31 | $36M | 1.0M | 35.66 |
| 2015-09-30 | $28M | 1.0M | 27.78 |
| 2015-06-30 | $48M | 1.2M | 41.89 |
| 2015-03-31 | $44M | 1.4M | 32.60 |
| 2014-12-31 | $48M | 1.5M | 31.75 |
| 2014-09-30 | $24M | 958k | 24.76 |
| 2014-06-30 | $22M | 950k | 22.60 |
| 2014-03-31 | $21M | 842k | 24.32 |
| 2013-12-31 | $21M | 820k | 24.98 |
| 2013-09-30 | $25M | 892k | 27.48 |
| 2013-06-30 | $16M | 888k | 18.15 |